Skip to main content
CI
NYSE Finance

Cigna Q2 Earnings Beat, Raises 2026 Outlook to at Least $30.45/Share

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$291.88
Mkt Cap
$78.426B
52W Low
$239.51
52W High
$315.47
52W Position info
22% above low
Off High info
7.5% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CI sits 22% above its 52-week low of $239.51.

Summary

Cigna reported Q2 2026 adjusted EPS of $7.78, up 8% year-over-year, and raised its full-year outlook to at least $30.45 per share, driven by strong performance in its health insurance segment.


Key Events · Earnings and Guidance · CI

  • Q2 Earnings Beat

    Adjusted EPS of $7.78 vs. $7.20 a year ago, on revenue of $71.7B (+7% YoY).

  • Full-Year Guidance Raised

    2026 adjusted EPS outlook increased to at least $30.45 from prior $30.35; Cigna Healthcare pre-tax income outlook raised by $25M to at least $4.55B.

  • Segment Performance

    Cigna Healthcare pre-tax adjusted income rose 17% to $1.28B; Evernorth pre-tax adjusted income fell 2% to $1.66B due to client-focused investments.

  • Share Repurchases

    Year-to-date through July 29, 2026, repurchased 0.9M shares for approximately $250M.


Analysis · CI · Finance

A strong second quarter saw revenue climb 7% to $71.7 billion, with adjusted EPS reaching $7.78—well above the prior-year's $7.20. Confidence in the diversified health services portfolio prompted management to lift the full-year 2026 adjusted EPS guidance to at least $30.45. The beat was fueled by Cigna Healthcare, where pre-tax adjusted income surged 17%, while Evernorth posted a modest decline tied to client-focused investments. These results underscore the company's ability to navigate a complex healthcare landscape, though pharmacy customer attrition and medical cost trends warrant monitoring.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CI was trading at $291.88 on NYSE in the Finance sector, with a market capitalization of approximately $78.4B. The 52-week trading range was $239.51 to $315.47. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Nov 05, 2026, 1:00 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $302.34
Real-time Price: $296.99 info
Change: -$5.35 (-2%) info
Market Cap: $78.26B info
CI
Nov 05, 2026, 11:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $312.17
Real-time Price: $296.99 info
Change: -$15.18 (-5%) info
Market Cap: $78.26B info
CI
Nov 05, 2026, 6:51 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $296.99 info
Change: -$10.27 (-3%) info
Market Cap: $78.26B info
CI
Nov 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $296.99 info
Change: -$10.27 (-3%) info
Market Cap: $78.26B info
CI
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $300.90
Real-time Price: $296.99 info
Change: -$3.91 (-1%) info
Market Cap: $78.26B info